Cancer Treatment Development Research Related


People Related To Cancer Treatment Development Research

Samy Y. Lamouille, Ph.D.

Assistant Professor, Basic Science Education, Virginia Tech Carilion School of Medicine

Research Assistant Professor, Biological Sciences, College of Science, Virginia Tech

Research Assistant Professor, Fralin Biomedical Research Institute at VTC

Zhi Sheng, Ph.D.

Assistant Professor, Fralin Biomedical Research Institute at VTC

Assistant Professor of Internal Medicine, Virginia Tech Carilion School of Medicine

Harald Sontheimer, Ph.D.

Professor and Commonwealth Eminent Scholar in Cancer Research, Fralin Biomedical Research Institute at VTC

Director, Center for Glial Biology in Health, Disease, and Cancer

Executive Director, School of Neuroscience, College of Science, Virginia Tech

I. D. Wilson Chair in the College of Science, Virginia Tech

Events Related To Cancer Treatment Development

Exploiting Viruses to Understand and Treat Cancer

Dec. 11, 2015, 11 a.m. at Fralin Biomedical Research Institute

Clodagh O’Shea, PhD


Associate Professor, Molecular and Cell Biology Laboratory; William Scandling Developmental Chair, The Salk Institute

Pioneers in Biomedical Research Program

Patient-Defined Treatment Success and Preferences in Advanced-Stage Lung Cancer Patients

Aug. 11, 2015, 12:30 p.m. at Fralin Biomedical Research Institute

Monirul Islam, MD, PhD


Associate Professor of Epidemiology
College of Public Health
University of Nebraska Medical Center
Omaha, Nebraska

Special Seminars

Exosomes as an Emerging Target in Cancer Progression and a Nanovector for Cancer Therapy

Sept. 16, 2013, 4 p.m. at Fralin Biomedical Research Institute

Huang-Ge Zhang, DVM, PhD


Professor and Founders’ Chair in Cancer Research, James Graham Brown Cancer Center, Director of the Chemoprevention Program, University of Louisville

Special Seminars

Personalized Cancer Medicine: Are We There Yet?

Dec. 6, 2012, 5:30 p.m. at Fralin Biomedical Research Institute

Eileen Dolan, PhD


Professor of Medicine, Section of Hematology/Oncology; Co-Director, Clinical and Experimental Therapeutics Program of the Comprehensive Cancer Center, University of Chicago, Illinois

Maury Strauss Distinguished Public Lectures

Improving Cancer Therapy: By Targeting Metastasis, Chemoresistance, and Cachexia

Nov. 27, 2012, 1 p.m. at Fralin Biomedical Research Institute

Swarnali Acharyya


PhD

Special Seminars

Dissecting Systemic Mediators of Cancer Therapy Resistance and Metastasis

Nov. 26, 2012, 4 p.m. at Fralin Biomedical Research Institute

Swarnali Acharyya


PhD

Special Seminars

How Does Paclitaxel Work as a Cancer Medicine?

Feb. 10, 2012, 1 p.m. at Fralin Biomedical Research Institute

Timothy J. Mitchison, PhD


Hasib Sabbagh Professor of Systems Biology, Harvard Medical School, Boston, Massachusetts

Maury Strauss Distinguished Public Lectures

Neural Stem Cell-Based Virotherapy for Malignant Glioma

Oct. 31, 2011, 4 p.m. at Fralin Biomedical Research Institute

Atique Ahmed, PhD


Senior Research Associate, Department of Surgery, Section of Neurosurgery, University of Chicago, Chicago, Illinois

Special Seminars

Stories Related To Cancer Treatment Development

Researchers find way to make resistant brain cancer cells sensitive to treatment

Nov. 16, 2015

Scientists from the Virginia Tech Carilion Research Institute and clinicians from Carilion Clinic have discovered how to sensitize drug-resistant human glioblastoma cells to chemotherapy.

Institute scientists visualize potential brain cancer treatments in real time

April 9, 2015

Virginia Tech Carilion Research Institute scientists have developed new imaging techniques to watch dangerous brain tumor cells respond to treatment in real time.

Publications Related To Cancer Treatment Development

Sheng Z, Evans KS, and Green MR. (2010). An activating transcription factor 5-mediated survival pathway as a target for cancer therapy. Oncotarget 1(6): 457-460.